1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ANAPTYSBIO INC
AnaptysBio Inc XNAS: ANAB

AnaptysBio Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, inclu...

Read More
33.56 -0.42 (-1.24%)
New 52W High in past week
733.6K
XNAS Volume
High vol. this week

XNAS 11 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for AnaptysBio Inc is on 17 Nov 2025 for the purpose of Jefferies Global Healthcare Conference See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
9.5 / 100
Momentum Score
Technically Moderately Bullish
65.0 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
66
1Yr Price target upside is 96%
11 analysts

21

S

11

W

3

O

1

T

SWOT Analysis

AnaptysBio Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..